Table 3.
Anemia according to disease status and treatment status at enrollment (evaluable population)
| Anemic (%) | |||||
|---|---|---|---|---|---|
| Enrollment n (%) | Overall | <8.0 g/dL | 8.0–9.9 g/dL | 10.0–11.9 g/dL | |
| Disease status | |||||
| Newly diagnosed, no treatment | 481 (20.9) | 47.0 | 2.3 | 14.2 | 30.5 |
| Newly diagnosed, with treatment | 516 (22.4) | 50.1 | 2.0 | 14.7 | 33.5 |
| Persistent/recurrent disease | 893 (38.8) | 63.8 | 5.0 | 20.9 | 37.9 |
| In remission | 412 (17.9) | 37.8 | 0.8 | 10.1 | 26.9 |
| Treatment status | |||||
| No treatment | 1021 (44.9) | 45.4 | 2.4 | 14.2 | 28.8 |
| Chemotherapy (CT) | 1186 (52.1) | 58.6 | 3.5 | 17.9 | 37.2 |
| Radiotherapy (RT) | 47 (2.1) | 42.6 | 0 | 6.4 | 36.2 |
| Concomitant CT/RT | 22 (1.0) | 72.7 | 4.5 | 36.4 | 31.8 |